According to FutureWise analysis, the market for Contraceptive Devices in 2023 is US$12.4 billion, and is expected to reach US$19.5 billion by 2031 at a CAGR of 5.80%.

The global contraceptive devices market was valued at approximately USD 14.8 billion in 2024 and is anticipated to experience robust growth, reaching an estimated USD 23.5 billion by 2037. This trajectory represents a compound annual growth rate (CAGR) of around 5.1% from 2025 through 2037. This impressive expansion is fueled by several key factors, including a heightened awareness of reproductive health issues, an increasing adoption of long-acting reversible contraceptives (LARCs) such as intrauterine devices (IUDs) and implants, government-supported family planning initiatives, and a rise in sexually transmitted diseases (STDs). Within this evolving landscape, condoms continue to dominate the product segment due to their ease of use, widespread availability, and effectiveness in providing barrier protection. However, implants and IUDs are emerging as the fastest-growing contraceptive options, reflecting a shift in consumer preferences towards more sustainable and effective long-term solutions. The strongest regional growth is expected in the Asia-Pacific region, where vibrant population dynamics and enhanced access to healthcare services in emerging markets are driving increased utilization of contraceptive methods. This growth marks a significant step toward enhancing reproductive health outcomes and empowering individuals with greater control over their family planning decisions.

FutureWise Market Research has released a report that provides an intricate analysis of Contraceptive Devices Market trends that shall affect the overall market growth. Furthermore, it includes detailed information on the graph of profitability, SWOT analysis, market share and regional proliferation of this business. Moreover, the report offers insights on the current stature of prominent market players in the competitive landscape analysis of this market.

Request a Free Sample @

https://www.futurewiseresearch.com/contact.aspx?rpt=10294&type=requestsample

Contraceptive Devices Market Segmentation:

By Product Type

• Male Contraceptive Devices
• Female Contraceptive Devices
• Female Condoms, Diaphragms and Sponges
• Vaginal Rings
• Intrauterine Devices
• Sub-dermal Implants
• Others

By Technology

• Hormonal Contraceptives
• Barrier Contraceptives

By Distribution Channel

• Hospital Pharmacy
• Retail Pharmacy
• Clinics
• Online Channels
• Public Channel and NGO
• Others

By Region

• North America
• Europe
• Asia-Pacific
• Latin America
• Middle East and Africa

Competitive Landscape in Contraceptive Devices Market:

• Bayer AG
• Pfizer Inc.
• Janssen Global Services, LLC
• Teva Pharmaceutical Industries Ltd.
• Merck & Co., Inc.
• Mylan N.V.
• Allergan
• Reckitt Benckiser Group plc
• Veru Inc.
• Church & Dwight Co., Inc.
• Medisafe Distribution Inc.
• Cooper Surgical Inc.
• DKT International
• Pregna International Limited
• HLL Lifecare Limited
• Mankind Pharma
• TTK HealthCare
• Boehringer Ingelheim International GmbH
• V-Care Pharma Pvt. Ltd.
• Vardhaman Lifecare Pvt Ltd, Cipla Inc.

Buy now the latest version of this report: https://www.futurewiseresearch.com/checkout.aspx?ReportId=10294&license=multi

**Objectives of this Study: **

1. To provide a comprehensive analysis of the Contraceptive Devices Market By Product Type, By Technology, By Distribution Channel and By Region.
2. To offer detailed insights into factors such as drivers, restraints, trends, and opportunities, as well as segmental and regional influences on market growth.
3. To evaluate current market trends and forecast micro-markets, presenting overall market projections in the form of data sets and PowerPoint presentations.
4. To predict the market size in key regions, including North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa.

                                                                                                                
Flexible Delivery Model:

• We have a flexible delivery model and you can suggest changes in the scope/table of contents as per your requirement
• The customization services offered are free of charge with the purchase of any license of the report.
• You can directly share your requirements/changes to the current table of contents to: sales@futurewiseresearch.com